Corporate GovernanceApr 29, 2026, 04:33 PM
BCAB Amends 2025 10-K to Add Part III Info; 50-for-1 Share Consolidation
AI Summary
BioAtla, Inc. filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The amendment primarily includes information required by Part III of Form 10-K, covering directors, executive officers, corporate governance, executive compensation, and related matters, which was previously omitted. Additionally, the company disclosed a 50-for-1 share consolidation effective April 6, 2026, with all share and per share amounts retroactively adjusted. New certifications from the principal executive and financial officers were also filed.
Key Highlights
- Amended 2025 Form 10-K/A filed to include Part III information previously omitted.
- Part III details Directors, Executive Officers, Corporate Governance, and Executive Compensation.
- Company effected a 50-for-1 share consolidation on April 6, 2026.
- All share and per share amounts in the amendment retroactively adjusted for consolidation.
- New certifications (Exhibits 31.3 and 31.4) filed by principal officers.
- Board of Directors consists of 7 members as of March 31, 2026.
- Board diversity includes 3 female and 4 male directors.
- Board met 6 times in 2025; audit committee met 9 times.